Search research articles
Contact Us
Filters
Showing results (11-20 of 76) with videos related to
Page
of 8
Sort By:
Journal of Medical Economics
|
October 16, 2009
Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD
Anand A Dalal, Hans Petersen, Linda Simoni-Wastila, et al.
The American Journal of Managed Care
|
July 10, 2008
Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease
Manabu Akazawa, D Courtney Hayflinger, Richard H Stanford, et al.
Current Medical Research and Opinion
|
July 23, 2009
Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population
Xin Ye, Benjamin Gutierrez, Victoria Zarotsky, et al.
Annals of Epidemiology
|
February 12, 2008
A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population
Christopher M Blanchette, Linda Simoni-Wastila, Ilene H Zuckerman, et al.
Journal of Managed Care Pharmacy : JMCP
|
March 12, 2008
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population
Christopher M Blanchette, Benjamin Gutierrez, Caron Ory, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
March 27, 2010
The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management
Douglas W Mapel, Judith S Hurley, Anand A Dalal, et al.
BMC Surgery
|
August 17, 2014
A cross-sectional retrospective analysis of the regionalization of complex surgery
James Studnicki, Christopher Craver, Christopher M Blanchette, et al.
Drugs in Context
|
August 20, 2016
Evaluating cost benefits of combination therapies for advanced melanoma
Ivar S Jensen, Emily Zacherle, Christopher M Blanchette, et al.
Health Services Research
|
March 29, 2008
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage
Linda Simoni-Wastila, Ilene H Zuckerman, Thomas Shaffer, et al.
American Health & Drug Benefits
|
January 8, 2020
Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States
Michael C Runken, Joshua M Noone, Christopher M Blanchette, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 76) with videos related to
Sort By:
Page
of 8
Journal of Medical Economics
|
October 16, 2009
Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD
Anand A Dalal, Hans Petersen, Linda Simoni-Wastila, et al.
The American Journal of Managed Care
|
July 10, 2008
Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease
Manabu Akazawa, D Courtney Hayflinger, Richard H Stanford, et al.
Current Medical Research and Opinion
|
July 23, 2009
Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population
Xin Ye, Benjamin Gutierrez, Victoria Zarotsky, et al.
Annals of Epidemiology
|
February 12, 2008
A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population
Christopher M Blanchette, Linda Simoni-Wastila, Ilene H Zuckerman, et al.
Journal of Managed Care Pharmacy : JMCP
|
March 12, 2008
Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population
Christopher M Blanchette, Benjamin Gutierrez, Caron Ory, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
March 27, 2010
The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management
Douglas W Mapel, Judith S Hurley, Anand A Dalal, et al.
BMC Surgery
|
August 17, 2014
A cross-sectional retrospective analysis of the regionalization of complex surgery
James Studnicki, Christopher Craver, Christopher M Blanchette, et al.
Drugs in Context
|
August 20, 2016
Evaluating cost benefits of combination therapies for advanced melanoma
Ivar S Jensen, Emily Zacherle, Christopher M Blanchette, et al.
Health Services Research
|
March 29, 2008
Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage
Linda Simoni-Wastila, Ilene H Zuckerman, Thomas Shaffer, et al.
American Health & Drug Benefits
|
January 8, 2020
Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States
Michael C Runken, Joshua M Noone, Christopher M Blanchette, et al.
Page
of 8